
Join to view full profile
50 Staniford St# 7Boston, MA 02114
Phone+1 617-726-3934
Dr. Bhan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Harvard T.H. Chan School of Public HealthMPH, Clinical Effectiveness, 2005 - 2008
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2004 - 2008
Mass General Brigham/Massachusetts General HospitalChief Residency, Internal Medicine, 2005 - 2006
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
Harvard Medical SchoolClass of 2001
Certifications & Licensure
MA State Medical License 2003 - 2028
Clinical Trials
Publications & Presentations
PubMed
- 45 citationsPhase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour
Clinical Journal of the American Society of Nephrology. 2024-04-01 - 13 citationsResults of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuria.Anna Gaya, Talha Munir, Alvaro Urbano-Ispizua, Morag Griffin, Jorg Taubel
Ejhaem. 2023-08-01 - 63 citationsLumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.Mini Michael, Jaap W Groothoff, Hadas Shasha-Lavsky, John C Lieske, Yaacov Frishberg
American Journal of Kidney Diseases. 2023-02-01
Lectures
- Primary Care Internal Medicine: Principles and PracticeHarvard Medical School ,Department Of Continuing Education, Cambridge, Massachusetts - 10/14/2013
- Primary Care Internal Medicine: Principles and PracticeHarvard Medical School ,Department Of Continuing Education, Cambridge, Massachusetts - 10/14/2013
Press Mentions
- Why SHPT Remains Difficult to TreatMay 12th, 2016
Vitamin D Treatment Not Found to Reduce Cardiovascular Abnormalities in Kidney Disease PatientsFebruary 14th, 2012
Tests of Resistance to Hormone Could Help Doctors Monitor and Treat Kidney Disease PatientsFebruary 10th, 2016
Grant Support
- Human Cathelicidin (HCAP18) In Chronic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









